Maryll W. Toufanian
Corporate Officer/Principal presso AMNEAL PHARMACEUTICALS, INC.
Profilo
Maryll W.
Toufanian is currently the Senior Vice President-Regulatory Strategy & Policy at Amneal Intermediate, Inc. and also holds the position of Senior VP-Regulatory Strategy & Policy at Amneal Pharmaceuticals, Inc. She has an undergraduate degree from the University of Maine and graduate degrees from New York University School of Law and the University of Texas at Austin.
Posizioni attive di Maryll W. Toufanian
Società | Posizione | Inizio |
---|---|---|
AMNEAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 31/10/2022 |
Formazione di Maryll W. Toufanian
New York University School of Law | Graduate Degree |
University of Texas at Austin | Graduate Degree |
University of Maine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMNEAL PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Borsa valori
- Insiders
- Maryll W. Toufanian